HempCBD Investor Magazine Issue #3 - July / August 2020 | Page 42

Q

HCI: Many companies have been advertising their CBD products to include a certain amount of CBD, but research has found that the levels of CBD companies claim are sometimes false and misleading. Are your products lab tested?

A

GZP: Yes, we do both in house testing and third-party testing. One of our main benefits when compared to our competition is that we add 110% of the formulated amount into every CBD product we manufacture.

Q

HCI: Do you have a plan to expand outside the Unites States?

A

GZP: We will look at that in a year or so, but for right now we're looking to expand coast to coast within the US.

Q

HCI: Isn’t it a learning curve for consumers when it comes to CBD? How do you plan on educating consumers?

A

GZP: We have extensive educational tools when it comes to CBD. Clients come to our store to learn about CBD. So yes, you are right, but we have been doing great and plan to expand our educational footprint.

Q

A

HCI: Why do you think there is market demand in the United States for Hemp-derived CBD?

GZP: Just look at the market for pain, sleep, stress and anxiety. It is in the billions. The market is there. The product works fantastically. It is natural and you do not get hooked on it and people are moving over from synthetic drugs to CBD every day. Only 14% of people have tried CBD in a 2019 gallop poll. That is a lot of market share left to be had in the future.

INVEST A MINIMUM OF $200